×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
TFDA Town Hall: Focus on Regenerative Medicine
Session Chair(s)
Shou-Mei Wu, PhD
Director-General
TFDA, Taiwan
Regenerative medicine is a potential treatment that can help repair or replace damaged or diseased human cells or tissues to restore normal function. This forum will discuss the regulatory aspects and experience with regenerative medicine.
Learning Objective : Discuss regulations governing implementation or use of specific medical technology, examination, laboratory testing and medical devices; Describe the management of regenerative pharmaceutical products; Describe the experience of reviewing regenerative medicine affairs.
Speaker(s)
New Regulation on Cell Therapy: Challenge and Prospect
Chung-Liang Shih, PhD
Ministry of Health & Welfare, Taiwan
Director-General, Department of Medical Affairs
Regulation of Cell and Gene Therapy Products
Lien-Cheng Chang, PhD
Academia Sinica, Taiwan
Senior Secretary, Department of Intellectual Property and Technology Transfer
Regulatory Considerations and Experiences for the Evaluation of Regenerative Medicinal Products
I-Ning Tang, MD, MSc
Center for Drug Evaluation (CDE), Taiwan
Section Chief, Regulatory Science
Have an account?